{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:39:22Z","timestamp":1761975562533,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R35HL139854"],"award-info":[{"award-number":["1R35HL139854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaip.2021.06.046","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T02:18:36Z","timestamp":1626315516000},"page":"3331-3338.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of Varying Clinical Manifestations and Positive Anti\u2013SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study"],"prefix":"10.1016","volume":"9","author":[{"given":"Jonathan I.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Zyskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiam","family":"Naiditch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron E.","family":"Glatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elitza S.","family":"Theel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Joyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Ashley","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Bigajer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Stok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.06.046_bib1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.06.046_bib2","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/s41467-020-19943-y","article-title":"Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2021.06.046_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from Covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.06.046_bib4","doi-asserted-by":"crossref","first-page":"ftaa069","DOI":"10.1093\/femspd\/ftaa069","article-title":"How can we interpret SARS-CoV-2 antibody test results?","volume":"79","author":"Fons","year":"2021","journal-title":"Pathog Dis"},{"key":"10.1016\/j.jaip.2021.06.046_bib5","article-title":"Dynamics and significance of the antibody response to SARS-CoV-2 infection","author":"Iyer","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jaip.2021.06.046_bib6","article-title":"SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike","author":"Guthmiller","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jaip.2021.06.046_bib7","article-title":"Identification of optimal symptom combinations to trigger diagnostic work-up of suspected COVID-19 cases: analysis from a community-based, prospective, observational cohort","author":"Antonelli","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jaip.2021.06.046_bib8","doi-asserted-by":"crossref","first-page":"e0234765","DOI":"10.1371\/journal.pone.0234765","article-title":"The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries","volume":"15","author":"Grant","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2021.06.046_bib9","doi-asserted-by":"crossref","first-page":"e212816","DOI":"10.1001\/jamanetworkopen.2021.2816","article-title":"SARS-CoV-2 seroprevalence and symptom onset in culturally linked orthodox Jewish communities across multiple regions in the United States","volume":"4","author":"Zyskind","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.06.046_bib10","doi-asserted-by":"crossref","first-page":"e01243-20","DOI":"10.1128\/JCM.01243-20","article-title":"Performance characteristics of four high-throughput immunoassays for detection of IgG antibodies against SARS-CoV-2","volume":"58","author":"Theel","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jaip.2021.06.046_bib11","doi-asserted-by":"crossref","first-page":"e217105","DOI":"10.1001\/jamanetworkopen.2021.7105","article-title":"Comparison of COVID-19 incidence rates before and after school reopening in Israel","volume":"4","author":"Somekh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.06.046_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamapediatrics.2021.0001","article-title":"Prevalence of SARS-CoV-2 infection in children and their parents in Southwest Germany","volume":"175","author":"Tonshoff","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2021.06.046_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.06.046_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","article-title":"Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment","volume":"14","author":"Lanza","year":"2013","journal-title":"Prev Sci"},{"key":"10.1016\/j.jaip.2021.06.046_bib15","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2021.06.046_bib16","doi-asserted-by":"crossref","first-page":"m2911","DOI":"10.1136\/bmj.m2911","article-title":"Covid-19: study reveals six clusters of symptoms that could be used as a clinical prediction tool","volume":"370","author":"Wise","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.06.046_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.06.046_bib18","doi-asserted-by":"crossref","first-page":"e0241104","DOI":"10.1371\/journal.pone.0241104","article-title":"Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders","volume":"15","author":"Marklund","year":"2020","journal-title":"PLoS One"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821007790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821007790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:29:11Z","timestamp":1761974951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821007790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213219821007790"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.046","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Varying Clinical Manifestations and Positive Anti\u2013SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}